2-bromo-5-nitroanisol | CAS:77337-82-7

We serve 2-bromo-5-nitroanisol CAS:77337-82-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
2-bromo-5-nitroanisol

Chemical Name:2-bromo-5-nitroanisol
CAS.NO:77337-82-7
Synonyms:2-bromo-5-nitroanisol
1-Bromo-2-methoxy-4-nitrobenzene
 
Physical and Chemical Properties:
Density 1.6±0.1 g/cm3
Boiling Point 302.1±22.0 °C at 760 mmHg
Melting Point 99-103 °C
Molecular Formula C7H6BrNO3
Molecular Weight 232.031
Flash Point 136.5±22.3 °C
Vapour Pressure 0.0±0.6 mmHg at 25°C
Index of Refraction 1.581
 
Specification:
Appearance:Yellow crystalline powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Organic synthesis.



Contact us for information like 2-bromo-5-nitroanisol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-Bromo-2-methoxy-4-nitrobenzene physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-bromo-5-nitroanisol Use and application,2-bromo-5-nitroanisol technical grade,usp/ep/jp grade.


Related News: British Airways, Qantas and Lufthansa — among others — have announced they will stop flying to mainland China. Other airlines are reducing the number of flights.guanine manufacturer The Company’s immuno-regulatory product candidates include ProTmune, a pharmacologically modulated, donor cell graft that is currently being evaluated in a Phase 2 clinical trial for the prevention of graft-versus-host disease, and a myeloid-derived suppressor cell immunotherapy for promoting immune tolerance in patients with immune disorders. Fate Therapeutics is headquartered in San Diego, CA.1,2,3-Trifluorobenzene supplier Factors that have a significant impact on the sales volume of APIs come from the production side, which mainly includes costs and processes.(3aR,4S,7R,7aS)-Hexahydro-1H-4,7-methanoisoindole-1,3(2H)-dione vendor It is delivered to hospitals and pharmacies until it reaches the patient.At present, Teva can produce more than 300 generic drugs, and the API department has approximately 650 authorized patents and patent applications worldwide. It is also the generic drug company with the most challenges in patenting ParagraphIV in the world.